Composite and multicomponent end points in clinical trials.
Sign Up to like & getrecommendations! Published in 2017 at "Statistics in medicine"
DOI: 10.1002/sim.7386
Abstract: In January 2017, the FDA released the draft guidance to industry on multiple end points in clinical trials. A class of multiplicity problems arise from the testing of individual or subset of components of a… read more here.
Keywords: end points; end; clinical trials; composite multicomponent ... See more keywords